Pharma PR Newswire

Pharma Focus Asia offers the most advanced strategies in Pharmaceutical Sector, the most significant developments in the industry and provides information on the latest research in Pharma Healthcare. The following Press Releases highlights the recent happenings in the Pharmaceutical Sector across the world.

AOBiome and its Consumer Division, Mother Dirt, Founding members of the Microbiome Coalition, Helps Launch of the National Microbiome Initiative

Monday, May 23, 2016 PR Newswire

CAMBRIDGE Mass May 23 2016 PRNewswire On May 13 2016 the White House Office of Science and Technology Policy announced the launch of the National Microbiome Initiative The initiative aims to increase awareness and understanding along with promoting research and knowledg..

DS Biopharma Announces DS102 will be Developed for Pulmonary Disorders in Addition to NASH

Monday, May 23, 2016 PR Newswire

DUBLIN May 23 2016 PRNewswire DS Biopharma DS today announced plans to develop its antifibrotic and antiinflammatory compound DS102 in chronic obstructive pulmonary disease COPD patients as well as in nonalcoholic steatohepatitis NASH patients Recent DS preclinical data suggests that DS102 is s..

Luminex Corporation and Nanosphere, Inc. Provide Update on Acquisition Agreement

Monday, May 23, 2016 PR Newswire

AUSTIN Texas and NORTHBROOK Ill May 23 2016 PRNewswire Luminex Corporation NASDAQ LMNXand Nanosphere Inc NASDAQ NSPH announced today that they have entered into an amendment to the definitive agreement under which Luminex will acquire Nanospherea leader in the molecular microbiology and molecular ..

ImmunoCellular Therapeutics to Present at Marcum MicroCap Conference on June 2, 2016

Monday, May 23, 2016 PR Newswire

LOS ANGELES May 23 2016 PRNewswire ImmunoCellular Therapeutics Ltd ImmunoCellular NYSE MKT IMUC today announced that Andrew Gengos Chief Executive Officer of ImmunoCellular will present a corporate overview and business update at the Marcum MicroCap Conference on Thursday June 2 2016 at 200 pm ET..

OncoSec Announces $10 Million At-The-Market Registered Direct Offering

Monday, May 23, 2016 PR Newswire

SAN DIEGO May 23 2016 PRNewswire OncoSec Medical Incorporated OncoSec NASDAQ ONCS a company developing DNAbased intratumoral cancer immunotherapies announced today that it has entered into a definitive agreement with a single healthcare dedicated institutional fund to purchase approximately 10 mil..

Egalet Settles Patent Litigations with Purdue Pharma

Monday, May 23, 2016 PR Newswire

WAYNE Pa May 23 2016 PRNewswire Egalet Corporation Nasdaq EGLT Egalet a fully integrated specialty pharmaceutical company focused on developing manufacturing and commercializing innovative treatments for pain and other conditions today announced that it has reached an agreement with Purdue Pharma ..

Purdue Pharma Announces Patent Agreement with Egalet and Acura

Monday, May 23, 2016 PR Newswire

STAMFORD Conn May 23 2016 PRNewswire Purdue Pharma LPtoday announced that the Company has entered into an agreement with Egalet Corporation and Acura Pharmaceuticals Inc that will settle various patent claims As part of the agreement the companies will exchange valuable patent and regulatory right..

Synthetic Biologics Announces Detailed Data from Two SYN-010 Phase 2 Clinical Trials for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C)

Monday, May 23, 2016 PR Newswire

ROCKVILLE Md May 23 2016 PRNewswire Synthetic Biologics Inc NYSE MKT SYN a clinical stage company focused on developing therapeutics to protect the gut microbiome reported detailed data supporting positive clinical outcomes from two previously reported Phase 2 clinical trials of its proprietary SY..

Immunomix CEO and Oncosec VP to Host Fireside Chat

Monday, May 23, 2016 PR Newswire

ROCKVILLE Md May 23 2016 PRNewswire Tomorrow Immunomic Therapeutics Inc ITI CEO Bill Hearl PhD and Oncosec Medical Senior Vice President David Meininger PhD MBA will host a fireside chat to discuss both the buy and sell side of pharmaceutical negotiations The talk is part of the Tech Council of M..

Ionis Pharmaceuticals and MD Anderson Form Strategic Alliance to Advance Novel Cancer Therapeutics

Monday, May 23, 2016 PR Newswire

CARLSBAD Calif and HOUSTON May 23 2016 PRNewswire Ionis Pharmaceuticals Inc NASDAQ IONS and The University of Texas MD Anderson Cancer Center today announced the formation of a strategic alliance to discover and develop novel cancer therapeuticsCombining advances made with Ionis antisense technolo..

Biocept Announces Master Services Agreement with Pharma Company to Develop Liquid Biopsy Tests

Monday, May 23, 2016 PR Newswire

SAN DIEGO May 23 2016 PRNewswire Biocept Inc NASDAQ BIOC a leading molecular diagnostics company with liquid biopsy technology for cancer profiling and monitoring announces that it has entered into a master services agreement with a biopharmaceutical company to develop targeted liquid biopsy tests..

Bausch + Lomb Wins Walmart \"Supplier of the Year\" Award

Monday, May 23, 2016 PR Newswire

LAVAL Quebec May 23 2016 PRNewswire Valeant Pharmaceuticals International Inc NYSE VRX TSX VRX today announced that Walmart one of Valeants largest customers has presented Bausch Lomb with a Supplier of the Year Award for US Manufacturing in the Consumables and Health Wellness areas Bausch Lomb..

Gamida Cell Announces $4.4 Million Grant from the Israeli Government

Monday, May 23, 2016 PR Newswire

JERUSALEM May 23 2016 PRNewswire Gamida Cell a leader in cellular and immune therapies for the treatment of cancer and orphan genetic diseases announced today it has been awarded a grant of up to 44 million from the Israel Innovation Authority formerly the Office of the Chief Scientist of the Is..

Compugen to Present at the Jefferies Global Healthcare Conference in New York

Monday, May 23, 2016 PR Newswire

HOLON Israel May 23 2016 PRNewswire Compugen Ltd NASDAQ CGEN a leading predictive drug discovery company today announced that Ari Krashin Chief Financial and Operating Officer of Compugen will present a corporate overview and update at the Jefferies Global Healthcare Conference in New York NY on..

Oxitec CEO to Testify Before Congressional Committee on May 25th

Monday, May 23, 2016 PR Newswire

OXFORD England May 23 2016 PRNewswire Oxitec CEO Hadyn Parry will testify on Wednesday May 25th at 1015 am ET before the United States House Committee on Science Space and Technology about the role genetically engineered mosquitos can play in controlling the spread of the Aedes aegypti mosquito ..

Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2016

Monday, May 23, 2016 PR Newswire

WARSAW Ind May 23 2016 PRNewswire Zimmer Biomet Holdings Inc NYSE and SIX ZBH a global leader in musculoskeletal healthcare today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the second quarter of 2016 The cash dividend of 024 ..

Mylan Launches First Generic Doryx® Delayed-Release Tablets, 200 mg

Monday, May 23, 2016 PR Newswire

HERTFORDSHIRE England and PITTSBURGH May 23 2016 PRNewswire Mylan NV Nasdaq MYL TASE MYL today announced the US launch of Doxycycline Hyclate DelayedRelease DR Tablets USP 200 mg a generic version of Maynes Doryx Mylan received final approval from the US Food and Drug Administration FDA for its su..

Sinovac to Host Conference Call to Report First Quarter of 2016 Unaudited Financial Results

Friday, May 20, 2016 PR Newswire

BEIJING May 20 2016 PRNewswire Sinovac Biotech Ltd Nasdaq SVA a leading provider of biopharmaceutical products in China today announced that it will release its unaudited financial results for the first quarter ended March 31 2016 after the market closes on Thursday May 26 2016The Company will ho..

Regulus to Present New RG-012 Data at The 53rd European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Congress

Friday, May 20, 2016 PR Newswire

LA JOLLA Calif May 20 2016 PRNewswire Regulus Therapeutics Inc NASDAQ RGLS a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs today announced that new data on RG012 the companys antimiR targeting microRNA21 for the treatment of Alport synd..

Avalon Ventures and COI Pharmaceuticals Announce First Milestones for Sitari Pharmaceuticals and Silarus Therapeutics and Formation of Eighth Company

Friday, May 20, 2016 PR Newswire

SAN DIEGO May 20 2016 PRNewswire Avalon Ventures Avalon and COI Pharmaceuticals the Community Of Innovation established by Avalon today announced that the first two companies formed under the collaboration with GlaxoSmithKline GSK have achieved their first milestones Sitari Pharmaceuticals which ..

TOP